APA (7th ed.) Citation

MV, P., JS, S., NA, L. G., JS, P., FJ, T., MC, R. G., . . . JS, I. (2025). NLRP3 and beyond: Inflammasomes as central cellular hub and emerging therapeutic target in inflammation and disease. Frontiers in immunology, 16, 1624770. https://doi.org/10.3389/fimmu.2025.1624770

Chicago Style (17th ed.) Citation

MV, Pinzón-Fernández, et al. "NLRP3 and Beyond: Inflammasomes as Central Cellular Hub and Emerging Therapeutic Target in Inflammation and Disease." Frontiers in Immunology 16 (2025): 1624770. https://doi.org/10.3389/fimmu.2025.1624770.

MLA (9th ed.) Citation

MV, Pinzón-Fernández, et al. "NLRP3 and Beyond: Inflammasomes as Central Cellular Hub and Emerging Therapeutic Target in Inflammation and Disease." Frontiers in Immunology, vol. 16, 2025, p. 1624770, https://doi.org/10.3389/fimmu.2025.1624770.